Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 45 and 85 years old
- You are already scheduled for planned (non-emergency) heart bypass surgery
- Your overall health has been rated at a certain level by your anesthesia team (confirm with trial site for what this means for you)
- You are willing and able to sign a consent form agreeing to take part in the study
Who may not be able to join:
- Your surgery is needed urgently or in an emergency
- Your overall health has been rated as very poor or critical by your anesthesia team (confirm with trial site)
- You have a known allergy to local anesthetic medicines (numbing medicines)
- You have a blood clotting problem, such as low platelet counts or abnormal clotting test results (confirm with trial site for specific values)
- You have a skin infection at the area where an injection would need to be given
- You are pregnant
- You do not wish to sign the consent form or prefer not to participate after being given information about the study
⚠️ Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Merve Yaman, Assistant Professor, Kütahya Health Sciences University
Phone: +905363794742
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Postoperative pain intensity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.